These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2442419)
1. The effect of some urinary stone inhibitors on membrane interaction potentials of stone crystals. Mandel NS; Mandel GS; Hasegawa AT J Urol; 1987 Sep; 138(3):557-62. PubMed ID: 2442419 [TBL] [Abstract][Full Text] [Related]
2. Urolithiasis inhibitors and calculus nucleation. Grases F; Gil JJ; Conte A Urol Res; 1989; 17(3):163-6. PubMed ID: 2546313 [TBL] [Abstract][Full Text] [Related]
3. Influence of chondroitin sulfate, heparin sulfate, and citrate on Proteus mirabilis-induced struvite crystallization in vitro. McLean RJ; Downey J; Clapham L; Nickel JC J Urol; 1990 Nov; 144(5):1267-71. PubMed ID: 2122009 [TBL] [Abstract][Full Text] [Related]
4. Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine. Robertson WG; Scurr DS J Urol; 1986 Jun; 135(6):1322-6. PubMed ID: 2423714 [TBL] [Abstract][Full Text] [Related]
5. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439 [TBL] [Abstract][Full Text] [Related]
6. The effect of pH on the urinary inhibition of calcium oxalate crystal growth. Tiselius HG Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122 [TBL] [Abstract][Full Text] [Related]
7. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique. Ligabue A; Fini M; Robertson WG Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625 [TBL] [Abstract][Full Text] [Related]
8. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth. Senthil D; Subha K; Saravanan N; Varalakshmi P Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973 [TBL] [Abstract][Full Text] [Related]
9. Experiences with the measurement of inhibitory activity of urine and crystallisation inhibitors by different techniques. Baumann JM; Wacker M Urol Res; 1979 Sep; 7(3):183-8. PubMed ID: 228455 [TBL] [Abstract][Full Text] [Related]
10. [An architectural study of mixed uric acid and calcium oxalate stones by polarized light microscopy of thin section]. Takeuchi H; Arai Y; Konishi T; Tomoyoshi T Hinyokika Kiyo; 1988 Sep; 34(9):1529-35. PubMed ID: 3213788 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis. Grases F; Genestar C; Conte A; March P; Costa-Bauzá A Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195 [TBL] [Abstract][Full Text] [Related]
12. Analysis of urinary calculi by infrared spectroscopy. Lee YH; Chen MT; Huang JK; Chang LS Zhonghua Yi Xue Za Zhi (Taipei); 1990 Mar; 45(3):157-65. PubMed ID: 2168259 [TBL] [Abstract][Full Text] [Related]
14. The effect of monosodium urate on the capacity of urine, chondroitin sulphate and heparin to inhibit calcium oxalate crystal growth and aggregation. Ryall RL; Harnett RM; Marshall VR J Urol; 1986 Jan; 135(1):174-7. PubMed ID: 3079836 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine. Sidhu H; Gupta R; Thind SK; Nath R Urol Res; 1986; 14(6):299-303. PubMed ID: 3027939 [TBL] [Abstract][Full Text] [Related]
16. Scanning electron microscopic study of the effect of citrate and pyrophosphate on calcium oxalate crystal morphology. Shirane Y; Kagawa S J Urol; 1993 Dec; 150(6):1980-3. PubMed ID: 8230549 [TBL] [Abstract][Full Text] [Related]
17. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development. Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089 [TBL] [Abstract][Full Text] [Related]
18. [Gel model for measuring crystallization inhibitor activity]. Bothor C; Berg W; Börner RH; Jakob M Z Urol Nephrol; 1982 Oct; 75(10):689-98. PubMed ID: 6297185 [TBL] [Abstract][Full Text] [Related]